W7V Intrinsic Stock Value – WELL HEALTH TECHNOLOGIES Reports First Quarter FY2023 Earnings for Period Ending May 12 2023
May 27, 2023
Earnings Overview
On May 12, 2023, WELL HEALTH TECHNOLOGIES ($BER:W7V) reported total revenue of CAD 169.4 million for the first quarter of FY2023, ending on March 31, 2023 – a 33.9% year-over-year increase. Additionally, net income was reported at CAD -14.4 million, up from the -8.0 million reported in the same period the previous year.
Stock Price
Upon the announcement of its earnings report, WELL HEALTH TECHNOLOGIES stock opened at €3.6 and closed at €3.4, representing a 4.5% decline from its previous closing price. WELL HEALTH TECHNOLOGIES attributed its strong earnings to a focus on cost optimization and increased efficiencies throughout its operations. The company said it had invested heavily in technology and people to improve its customer engagements and drive more meaningful outcomes for clients. The company also noted that it had successfully launched new products and services, which had significantly contributed to increasing its customer base and revenue growth.
Despite the positive earnings report, WELL HEALTH TECHNOLOGIES’ stock experienced a decline in trading on Friday, potentially due to investor concerns over the uncertain macroeconomic environment in Europe in the coming months. Overall, it appears that WELL HEALTH TECHNOLOGIES is in a strong position to continue building on its successes in the coming quarters and deliver further value to its stakeholders. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for W7V. More…
| Total Revenues | Net Income | Net Margin |
| 612.05 | -4.5 | -1.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for W7V. More…
| Operations | Investing | Financing |
| 80.77 | -46.81 | -29.52 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for W7V. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.32k | 501.01 | 3.13 |
Key Ratios Snapshot
Some of the financial key ratios for W7V are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 158.0% | – | 5.5% |
| FCF Margin | ROE | ROA |
| 12.0% | 2.9% | 1.6% |
Analysis – W7V Intrinsic Stock Value
At GoodWhale, we have analyzed the wellbeing of WELL HEALTH TECHNOLOGIES and found that the fair value of its share is estimated to be around €15.3. This figure is derived from our proprietary Valuation Line which is based on a combination of qualitative and quantitative factors. Currently, WELL HEALTH TECHNOLOGIES stock is trading at €3.4, thus representing a significant undervaluation of 77.8%. We believe that this presents an attractive opportunity for investors who are looking to capitalize on the company’s considerable potential. More…
Summary
Investors in WELL HEALTH TECHNOLOGIES should be aware of the company’s performance in the first quarter of FY2023, ending on May 12 2023. The company reported a total revenue of CAD 169.4 million, an increase of 33.9% from last year. Unfortunately, the bottom line was not as promising as the top line, as net income reported a decrease from -8.0 million to -14.4 million in the same period.
These results were met with a negative reaction in the stock price on March 31 2023. Investors should weigh both the positive and negative figures to make an informed investing decision.
